LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of software and consulting services for pharmaceutical R&D and environmental toxicology, announced that it expects to file its Form 10-Q quarterly report for the third quarter of its 2010 fiscal year ended May 31, 2010, with the Securities and Exchange Commission on Thursday, July 15, 2010. Chairman and CEO Walt Woltosz will host a conference call to discuss the Company’s performance on Friday, July 16, 2010, at 8:30 a.m. PT / 11:30 a.m. ET.
The conference call will also be webcast live and may be accessed by first registering at the following website: https://www2.gotomeeting.com/register/637853155. Upon registering, you will receive a confirmation email with a unique link and instructions for joining the call. Please dial in five to ten minutes prior to the scheduled start time. For listen-only mode, you may dial 312-878-0211, and enter access code 388-997-864.
About Simulations Plus, Inc.
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. We also provide a productivity tool called Abbreviate! for PCs and the Apple iPhone as well as an educational software series for science students in middle and high schools known as FutureLab™. Our wholly owned subsidiary, Words+, Inc., provides assistive technologies to persons with disabilities, including the computerized communication system used by world-famous theoretical astrophysicist Professor Stephen Hawking. Simulations Plus, Inc., is headquartered in Southern California and trades on the NASDAQ Capital Market under the symbol “SLP.” For more information, visit our Web sites at www.simulations-plus.com and www.words-plus.com.